N, Jodka C, Hansen B, Denaro M: Glu-cose-lowering and insulin-sensitizingactions of exendin-4: studies in obese di-abetic ( ob/ob ,db/db ) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys(Macaca mulatta ).Diabetes 48:1026– 1034, 1999 11. Parkes DG, Pittner R, Jodka C, Smith P, Young A: Insulinotropic actions of ex-endin-4 and glucagon-like peptide-1 invivo and in vitro. Metabolism 50:583–589, 2001 12. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, BloomSR: Exendin-4 reduces fasting and post-prandial glucose and decreases energy in-take in healthy volunteers. Am J Physiol Endocrinol Metab 281:E155–E161, 2001 13. World Medical Association Declaration of Helsinski: recommendations guiding med-ical physicians in biomedical research in-volving human subjects. JAMA 277:925– 926, 1997 14. Fineman MS, Shen LZ, Kristin Taylor T,